Abstract
During the last three decades, there has been an increasingly productive interest in epidemiological research into Parkinson’s disease (PD); as a result, a number of descriptive and analytical epidemiological studies have been recently completed. Although the epidemiological profile of PD is not yet fully elucidated, these studies have appreciably advanced our knowledge of the epidemiological indices and natural course of PD, and furnished some clues relating to the unknown cause of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baumann RJ, Jameson HD, McKean HE, Haack DG, Weisberg LM (1980) Cigarette smoking and Parkinson’s disease. 1. A comparison of cases with matched neighbors. Neurology 30: 839–843
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415–455
Brewis M, Poskanzer DC, Rolland C, Miller H (1966) Neurological disease in an English city. Acta Neurol Scand [suppl 24]: 1–89
Dimsdale H (1946) Changes in the parkinsonian syndrome in the twentieth century. Q J Med 15: 155–170
Dupont E (1977) Epidemiology of parkinsonism: the Parkinson investigation, Arhus, Denmark. In: Worm-Petersen J, Böttcher J (eds) Symposium on Parkinsonism. Merck, Sharp and Dohme, Denmark, pp 65–75
Duvoisin RC, Yahr MD (1965) Encephalitis and parkinsonism. Arch Neurol 12: 227–239
Godwin-Austen RB, Lee PN, Marmot MG, Stern GM (1982) Smoking and Parkinson’s disease. J Neurol Neurosurg Psychiatry 45: 577–581
Gudmundsson KRA (1967) A clinical survey of Parkinsonism in Iceland. Acta Neurol Scand 43 [suppl 33]: 9–61
Haack DG, Baumann RJ, McKean HE, Jameson HD, Turbek JA (1981) Nicotine exposure and Parkinson’s disease. Am J Epidemiol 114: 191–200
Harada H, Nishikawa S, Takahashi K (1983) Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol 40: 151–154
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17: 427–442
Jenkins AC (1966) Epidemiology of Parkinsonism in Victoria. Med J Aust 2: 496–502
Kessler II (1972) Epidemiologic studies of Parkinson’s disease. II. Hospital based survey. Am J Epidemiol 95: 308–318
Kessler II (1972) Epidemiologic studies of Parkinson’s disease. III. A community based survey. Am J Epidemiol 96: 242–254
Kessler II, Diamond EL (1971) Epidemiologic studies of Parkinson’s disease. I. Smoking and Parkinson’s disease: a survey and explanatory hypothesis. Am J Epidemiol 94: 16–25
Kondo K (1984) Epidemiological clues for the etiology of Parkinson’s disease. Adv Neurol 40: 345–351
Kondo K, Shibasaki H (1981) Epidemiology of Parkinson’s disease. Clues for etiology. 12th World congress of neurology, International Congress Series 548. Excerpta Medica, Amsterdam, p 233
Kurland LT (1958) Epidemiology: incidence geographic distribution and genetic considerations. In: Fields WJ (ed) Pathogenesis and treatment of Parkinsonism. Charles C. Thomas, Springfield, 111, pp 5–49
Kurtzke JF, Kurland LT (1981) The epidemiology of neurologic disease. In: Baker AB, Baker LH (eds) Clinical neurology, vol 3, chap 48. Harper and Row, New York
Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979–980
Li S, Schoenberg BS, Wang C, Cheng X, Rui D, Bolis CL, Schoenberg DG (1985) A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China. Arch Neurol 42: 655–657
Lipkin LE (1959) Cytoplasmic inclusions in ganglion cells associated with parkinsonian states: a neurocellular change studied in 53 cases and 206 controls. Am J Pathol 35: 1117–1133
Maier Hoehn MM (1985) Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson’s disease. Acat Neurol Scand 71: 97–106
Marttila RJ, Rinne UK (1976) Epidemiology of Parkinson’s disease in Finland. Acta Neurol Scand 53: 81–102
Marttila RJ, Rinne UK (1976) Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson’s disease. A case-control study. Clin Neurol Neurosurg 76: 46–56
Marttila RJ, Rinne UK (1979) Changing epidemiology of Parkinson’s disease: predicted effects of levodopa treatment. Acta Neurol Scand 59: 80–87
Marttila RJ, Rinne UK (1980) Smoking and Parkinson’s disease. Acta Neurol Scand 62: 322–325
Marttila RJ, Rinne UK (1985) Clues from the epidemiology of Parkinson’s disease. Adv Neurol (in press)
Marttila RJ, Rinne UK, Siirtola T, Sonninen V (1977) Mortality of patients with Parkinson’s disease treated with levodopa. J Neurol 216: 147–153
Mutch W(1985) Parkinson’s disease in Aberdeen; 1983–1984. In: Social, epidemiological and therapeutic aspects of Parkinson’s disease. Abstracts. 5 Feb 1985, London
Nobrega FT, Glattre E, Kurland LT, Okazaki H (1969) Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935–1966. In: Barbeau A, Brünetter JR (eds) Progress in neuro-genetics. Excerpta Medica, Amsterdam, pp 474–485
dePedro J, Rosenqvist U (1984) Tracers for paralysis agitans in epidemiological research. II. A model for indirect estimation of the prevalence of the disease. Neuroepid 3: 97–107
Pollock M, Hornabrook RW (1966) The prevalence, natural history and dementia of Parkinson’s disease. Brain 89: 429–448
Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson’s disease. Evidence for a single etiology related to subclinical infection about 1920. J Chron Dis 16: 961–973
Pritchard PB, Netsky MG (1973) Prevalence of neoplasms and causes of death in paralysis agitans. Neurology 23: 215–222
Rajput AH, Offord KP, Beard CM, Kurland LT (1984) Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 16: 278–282
Reef HE (1977) Prevalence of Parkinson’s disease in a multiracial community. In: den Hartog Jager WA, Bruyn GW, Heijstee APJ (eds) 11th World congress of neurology. Excerpta Medica, Amsterdam, p 125
Rosati G, Granieri E, Pinna L, Aiello L, Tola R, De Bastini P, Pirisi A, Devoto MC (1980) The risk of Parkinson disease in Mediterranean people. Neurology 30: 250–255
Schoenberg BS, Anderson DW, Haerer AF (1982) Differences by race in the prevalence of Parkinson’s disease. Abstracts of the 7th international symposium on Parkinson’s disease, 27–30 June 1982, Frankfurt a. M., p 55
Schoenberg BS, Anderson DW, Haerer AF (1985) Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology 35: 841–845
Sweet RD, McDowell RH (1975) Five years’ treatment of Parkinson’s disease with levo- dopa. Ann Intern Med 83: 456–463
Todes CJ, Lees AJ (1985) The pre-morbid personality of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 48: 97–100
Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB (1983) Parkinson’s disease in 65 pairs of twins and in a set of quadruplets. Neurology 33: 815–824
Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB, Dambrosia J (1984) Parkinson’s disease in twins. Adv Neurol 40: 341–344
Yahr MD (1976) Evaluation of long-term therapy in Parkinson’s disease. Mortality and therapeutic efficacy. In: Birkmayer W, Hornykiewicz O (eds) Advances in Parkinsonism. Editiones Roche, Basle, pp 435–443
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Marttila, R.J., Rinne, U.K. (1986). Epidemiology of Parkinson’s Disease. In: Poeck, K., Freund, HJ., Gänshirt, H. (eds) Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70007-1_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-70007-1_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70009-5
Online ISBN: 978-3-642-70007-1
eBook Packages: Springer Book Archive